ALEC
Companies
NASDAQ
Alector Inc.
Health Care
$1.46
-$0.43 (-22.75%)
Price Chart
Overview
About ALEC
we are a biotech company based in san francisco dedicated to the discovery and development of novel therapies harnessing the power of immune system to treat neurodegenerative diseases such as alzheimer's disease.
Market Cap
$420.2M
Volume
2.0M
Avg. Volume
1.6M
P/E Ratio
-0.9256757
Dividend Yield
0.00%
Employees
269.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.85
High Correlation
Volatility
High (0.82)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ALEC shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$420.2M
Volume2.0M
P/E Ratio-0.93
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 9, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025